| 000 | 01766 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513114130.0 | ||
| 264 | 0 | _c19970807 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/39.3.411 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHoogkamp-Korstanje, J A | |
| 245 | 0 | 0 |
_aMulticentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cMar 1997 |
||
| 300 |
_a411-4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAmoxicillin _xpharmacology |
| 650 | 0 | 4 | _aAmoxicillin-Potassium Clavulanate Combination |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
| 650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
| 650 | 0 | 4 |
_aClarithromycin _xpharmacology |
| 650 | 0 | 4 |
_aClavulanic Acids _xpharmacology |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xpharmacology |
| 650 | 0 | 4 | _aFluoroquinolones |
| 650 | 0 | 4 |
_aHaemophilus influenzae _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aMoraxella catarrhalis _xdrug effects |
| 650 | 0 | 4 |
_aQuinolones _xpharmacology |
| 650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
| 700 | 1 | _aDirks-Go, S I | |
| 700 | 1 | _aKabel, P | |
| 700 | 1 | _aManson, W L | |
| 700 | 1 | _aStobberingh, E E | |
| 700 | 1 | _aVreede, R W | |
| 700 | 1 | _aDavies, B I | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 39 _gno. 3 _gp. 411-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/39.3.411 _zAvailable from publisher's website |
| 999 |
_c9079007 _d9079007 |
||